Egetis Therapeutics AB (publ) Cash Flow Reinvestment Rate
Latest as of March 2019:
0.00x
Egetis Therapeutics AB (publ) cash flow reinvestment rate. Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2019, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr28.02 Million. Explore EGTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr28.02 Million
SEK
Capital Expenditures
Skr0.00
SEK
Egetis Therapeutics AB (publ) Cash Flow Reinvestment Rate by Year (None–None)
Egetis Therapeutics AB (publ) cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Egetis Therapeutics AB (publ). For the full cash flow conversion analysis, see EGTX cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow